Comportamiento de los tumores malignos de tiroides en nuestro medio
Resumen
Palabras clave
Referencias
Saito T. Multiple endocrine neoplasia. Nippon Rinsho. 2004;62(5):962-6.
Jiménez C, Gagel RF. Genetic testing in endocrinology: lessons learned from experience with multiple endocrine neoplasia type 2. Growth Horm IGF Res. 2004;14 Suppl A:150-7.
Hundahl SA, fleming ID, Fremgen AM. In: A National Cancer Data Base report on 53 856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer. 1998;83(12):2638-48.
Khoo Ml, Asa SL, Witterick IJ. Thyroid calcification and its association with thyroid carcinoma. Head Neck. 2002;24(7):651-5.
Segovia IG, Gallowitsch Hj, Kresnik E, Kumnig G, Igerc I, Matschnig S, et al. Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria:1984-2001. Thyroid. 2004;14(4):227-86.
Iribarren C, Haselkorn T, Tekawa IS. Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer. 2001;93(5):745-50.
Tie Y, Mao JP, Liu B, Song Y, Dong Y, Sun ZX. Effect of Papillary Thyroid Carcinoma Related Gene PTC1 on Subcellular Localization and Function of ATM Cell. Ai Zheng. 2004;23(5):487-92.
Fraker DL, Skarulis M, Livolsi V: Thyroid tumors. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1740-1762.
Rajesh L, Saha M, Radhika S, Das Radotra B, Rajwanshi A. Morphometric image analysis of follicular lesions of the thyroid. Anal Quant Cytol Histol. 2004;26(2):117-20.
Sanders LE, Cady B. Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. Arch Surg. 1998;133(4):419-25.
Thyroid American Joint Committee on Cancer. In: AJCC Cancer Staging Manual. 6th ed. New York: Springer; 2002. p. 77-87.
Stephenson TJ. Papillary carcinoma of the thyroid: difficult yet fascinating model of oncogenesis and tumour progression. Pathology. 2004;44(5):498-500.
Guercioni G, Siquini W, Taccaliti A, Marmorale C. Surgical treatment of differentiated thyroid carcinoma. Ann Ital Chir. 2003;74(5):501-9.
Lennard CM, Patel A, Wilson J. Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer. Surgery. 2001;129(5):552-8.
Godballe C, Asschenfeldt P, Jorgensen KE. Prognostic factors in papillary and follicular thyroid carcinomas: p53 expression is a significant indicator of prognosis. Laryngoscope. 1998;108(2):243-9.
Voutilainen PE, Multanen MM, Leppäniemi AK. Prognosis after lymph node recurrence in papillary thyroid carcinoma depends on age. Thyroid. 2001;11(10):953-7.
Enlaces refback
- No hay ningún enlace refback.
Copyright (c) 2016 Yuri Medrano Plana, Félix Manuel Becerra Cabanes, José Luis Llovera Rodríguez, Mauricio Rafael Ortiz Vargas, Ramón Bladimir Ramírez Cárdenas, Sabrina Rebeca Santana Valencia